1 / 6

North America SGLT2 Inhibitors Market

rising consumption of diets high in sodium, sugars, and unhealthy fats across the region, coupled with low intake of fruits, vegetables, and whole grains, significantly contributes to conditions such as hypertension, insulin resistance, and kidney damage, ultimately leading to the onset of chronic diseases.

Dewid
Download Presentation

North America SGLT2 Inhibitors Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America SGLT2 Inhibitors Market North America SGLT2 Inhibitors Market Size Worth USD 16.37 Billion by 2034 | CAGR: 8.4% North America SGLT2 Inhibitors Market Share, Size, Trends, Industry Analysis Report: By Indication [Cardiovascular, Chronic Kidney Disease (CKD), Type 2 Diabetes, and Others], Drug, Distribution Channel, and Country (US and Canada) – Market Forecast, 2025–2034

  2. North America SGLT2 Inhibitors Market • The North America SGLT2 inhibitors market size was valued at USD 7.32 billion in 2024. • The North America SGLT2 inhibitors market size is expected to reach USD 16.37 billion by 2034, exhibiting a CAGR of 8.4% during 2025– 2034. Request To Sample : https://www.polarismarketresearch.com/industry-analysis/north- america-sglt2-inhibitors-market/request-for-sample

  3. North America SGLT2 Inhibitors Market • Key Market Players : • AstraZeneca • Boehringer Ingelheim International GmbH • Bristol-Myers Squibb Company • Eli Lilly and Company • Glenmark Pharmaceuticals Ltd. • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.) • Lexicon Pharmaceuticals, Inc. • Merck & Co., Inc. • Sanofi • Pfizer Inc

  4. North America SGLT2 Inhibitors Market • North America SGLT2 Inhibitors Market Report Highlights • By drug, in 2024, the Jardiance (Empagliflozin) segment accounted for the largest revenue share of the North America SGLT2 inhibitors market. Jardiance's robust clinical profile demonstrates significant benefits in reducing cardiovascular mortality and heart failure hospitalizations, making it a preferred choice for managing type 2 diabetes and associated cardiovascular risks. • The type 2 diabetes segment, based on indication, is expected to register the highest CAGR during the forecast period. Governments and healthcare organizations in North America implement policies and programs aimed at diabetes prevention, education, and treatment.

  5. ????? ??: Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally. ??????? ????: Polaris Market Research Phone: +1-929-297-9727 Email: sales@polarismarketresearch.com

More Related